Oxaliplatin
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Meitheal Pharmaceuticals Inc. | generic | 8 | SUPPLYING |
| Apotex Corp. | generic | 5 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 4 | SUPPLYING |
| Sandoz Inc | generic | 4 | SUPPLYING |
| Qilu Pharmaceutical Co. Ltd. | unknown | 3 | SUPPLYING |
| Gland Pharma Limited | generic | 3 | SUPPLYING |
| BluePoint Laboratories | relabeler | 2 | SUPPLYING |
| Sagent Pharmaceuticals | generic | 2 | SUPPLYING |
| Fosun Pharma USA Inc. | unknown | 2 | SUPPLYING |
| Baxter Healthcare Corporation | brand | 2 | SUPPLYING |
| Mylan Institutional LLC | unknown | 2 | SUPPLYING |
| Shandong New Time Pharmaceutical Co., Ltd. | unknown | 2 | SUPPLYING |
| Eugia US LLC | generic | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Oxaliplatin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Oncology.
Oxaliplatin Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Oncology.
Oxaliplatin Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Oncology.
Oxaliplatin Injection — reported in shortage by Sandoz Inc.. Therapeutic category: Oncology.
